Azathioprine and 6-Mercaptopurine for the Prevention of Postoperative Recurrence in Crohn's Disease : A Meta-Analysis of Controlled Trials with Individual Patient Data

被引：0
|
作者：
Peyrin-Biroulet, Laurent
Deltenre, Pierre
Ardizzone, Sandro
D'Haens, Geert R.
Hanauer, Stephen B.
Herfarth, Hans H.
Lemann, Marc
Colombel, Jean-Frederic
机构：
来源：
GASTROENTEROLOGY | 2009年 / 136卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A522 / A522
页数：1
相关论文
共 50 条
  • [31] Serum sickness associated with 6-mercaptopurine in a patient with Crohn's disease
    Andersen, JM
    Tiede, JJ
    PHARMACOTHERAPY, 1997, 17 (01): : 173 - 176
  • [32] Placebo Rates in Crohn's Disease Randomized Clinical Trials: An Individual Patient Data Meta-Analysis
    Solitano, Virginia
    Hogan, Malcolm
    Singh, Siddharth
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    Zou, Guangyong
    Yuan, Yuhong
    Sands, Bruce E.
    Feagan, Brian G.
    Dulai, Parambir S.
    Narula, Neeraj
    Ma, Christopher
    Jairath, Vipul
    GASTROENTEROLOGY, 2025, 168 (02) : 344 - 356
  • [33] Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease - Balance
    Jacobstein, DA
    Baldassano, RN
    INFLAMMATORY BOWEL DISEASES, 2005, 11 (02) : 203 - 205
  • [34] A Meta-Analysis of Efficacy and Safety of Infliximab for Prevention of Postoperative Recurrence in Patients with Crohn's Disease
    Huang, He
    Xu, Su
    Huang, Fubin
    Wang, Xia
    Chen, Yong
    Xu, Zhaoshan
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [35] Efficacy of mycophenolate mofetil in patients failing 6-mercaptopurine or azathioprine therapy for Crohn's disease
    Hassard, PV
    Vasiliauskas, EA
    Kam, LY
    Targan, SR
    Abreu, MT
    INFLAMMATORY BOWEL DISEASES, 2000, 6 (01) : 16 - 20
  • [36] 6-mercaptopurine pharmacokinetics and blood lymphocyte subpopulations in patients with Crohn's disease treated with azathioprine
    Cattan, S
    Lemann, M
    Thuillier, F
    Bengoufa, D
    Rabian, C
    Ngo, Y
    Bouhnik, Y
    Messing, B
    Rambaud, JC
    Modigliani, R
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1998, 22 (02): : 160 - 167
  • [37] Use of 6-mercaptopurine/azathioprine as the immunornodulator of choice for moderately active Crohn's disease - Pro
    Hyams, JS
    INFLAMMATORY BOWEL DISEASES, 2005, 11 (02) : 197 - 199
  • [38] Nocardia pneumonia in a patient with Crohn's disease receiving 6-mercaptopurine and infliximab
    Saleemuddin, Ashraf
    Govender, Praveen P.
    Farraye, Francis A.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 (07): : 708 - 709
  • [39] A cost-effectiveness analysis of alternative disease management strategies in patients with Crohn's disease treated with azathioprine or 6-mercaptopurine
    Dubinsky, MC
    Reyes, E
    Ofman, J
    Chiou, CF
    Wade, S
    Sandborn, WJ
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (10): : 2239 - 2247
  • [40] Treatment of Crohn's disease (CD) with 6-mercaptopurine (6-MP) in patients intolerant to azathioprine (AZA).
    Lemann, M
    Bouhnik, Y
    Corguille, MKL
    Bonnet, J
    Coffin, B
    Marteau, P
    Bitoun, A
    Messing, B
    Jian, R
    Matuchansky, C
    Modigliani, R
    Rambaud, JC
    GASTROENTEROLOGY, 1997, 112 (04) : A1025 - A1025
12345